These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 9642312)
1. A survey of antipsychotic treatment for schizophrenia in Hong Kong. Yip KC; Ungvari GS; Cheung HK; Ng FS; Lau ST Chin Med J (Engl); 1997 Oct; 110(10):792-6. PubMed ID: 9642312 [TBL] [Abstract][Full Text] [Related]
2. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals]. Bret P; Bret MC; Queuille E Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381 [TBL] [Abstract][Full Text] [Related]
3. Prescribing for inpatients with schizophrenia: an international multi-center comparative study. Bitter I; Chou JC; Ungvari GS; Tang WK; Xiang Z; Iwanami A; Gaszner P Pharmacopsychiatry; 2003 Jul; 36(4):143-9. PubMed ID: 12905100 [TBL] [Abstract][Full Text] [Related]
4. A prospective survey on drug choice for prescriptions for admitted patients with schizophrenia. Ito C; Kubota Y; Sato M Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S35-40. PubMed ID: 10560896 [TBL] [Abstract][Full Text] [Related]
5. Clinical correlates of antipsychotic polytherapy in patients with schizophrenia in Singapore. Sim K; Su A; Chan YH; Shinfuku N; Kua EH; Tan CH Psychiatry Clin Neurosci; 2004 Jun; 58(3):324-9. PubMed ID: 15149301 [TBL] [Abstract][Full Text] [Related]
6. Neuroleptic drug utilisation for acute schizophrenia. Razali MS; Hasanah CI Singapore Med J; 1996 Dec; 37(6):611-3. PubMed ID: 9104062 [TBL] [Abstract][Full Text] [Related]
7. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey. Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175 [TBL] [Abstract][Full Text] [Related]
8. Neuroleptic prescription for Chinese schizophrenics in Hong Kong. Chiu H; Lee S; Leung CM; Wing YK Aust N Z J Psychiatry; 1992 Jun; 26(2):262-4. PubMed ID: 1353673 [TBL] [Abstract][Full Text] [Related]
9. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand. Wheeler AJ Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732 [TBL] [Abstract][Full Text] [Related]
10. The pharmacological treatment of schizophrenia in Chinese patients: a comparison of prescription patterns between 1996 and 1999. Ungvari GS; Chung YG; Chee YK; Fung-Shing N; Kwong TW; Chiu HF Br J Clin Pharmacol; 2002 Oct; 54(4):437-44. PubMed ID: 12392594 [TBL] [Abstract][Full Text] [Related]
11. A prospective study on the pattern of medication use for schizophrenia in the outpatient pharmacy department, Hospital Tengku Ampuan Rahimah, Selangor, Malaysia. Ponto T; Ismail NI; Abdul Majeed AB; Marmaya NH; Zakaria ZA Methods Find Exp Clin Pharmacol; 2010; 32(6):427-32. PubMed ID: 20852752 [TBL] [Abstract][Full Text] [Related]
12. Exploring the clinical and social determinants of prescribing anticholinergic medication for Chinese patients with schizophrenia. Xiang YT; Weng YZ; Leung CM; Tang WK; Sandor UG Hum Psychopharmacol; 2007 Apr; 22(3):173-80. PubMed ID: 17397098 [TBL] [Abstract][Full Text] [Related]
13. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002. Mirandola M; Andretta M; Corbari L; Sorio A; Nosè M; Barbui C Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):412-20. PubMed ID: 16287199 [TBL] [Abstract][Full Text] [Related]
14. The use of antipsychotic medication in child and adolescent psychiatric treatment in Denmark. A cross-sectional survey. Deurell M; Weischer M; Pagsberg AK; Labianca J Nord J Psychiatry; 2008; 62(6):472-80. PubMed ID: 18841508 [TBL] [Abstract][Full Text] [Related]
15. Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders: a survey of 1,418 patients in Japan. Uchida H; Suzuki T; Mamo DC; Mulsant BH; Tanabe A; Inagaki A; Watanabe K; Yagi G; Tomita M Am J Geriatr Psychiatry; 2008 Jul; 16(7):584-93. PubMed ID: 18591578 [TBL] [Abstract][Full Text] [Related]
16. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit]. Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374 [TBL] [Abstract][Full Text] [Related]
17. Clinical and social determinants of antipsychotic polypharmacy for Chinese patients with schizophrenia. Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS Pharmacopsychiatry; 2007 Mar; 40(2):47-52. PubMed ID: 17447172 [TBL] [Abstract][Full Text] [Related]
18. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study. Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645 [TBL] [Abstract][Full Text] [Related]
19. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003. Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060 [TBL] [Abstract][Full Text] [Related]